Share
Jehanzeb Noor
Zimmer Biomet Holdings, Inc., a global leader in medical technology, has appointed Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation, and Business Development Officer.
Mr. Noor will report directly to Ivan Tornos, President and CEO of Zimmer Biomet.
In his new role, Mr. Noor will be responsible for spearheading strategy development and execution across the company, overseeing all aspects of mergers and acquisitions, including the integration of the pending acquisition of Paragon 28. Additionally, he will manage the research and product development organizations, focusing on new product and service development, partnerships, ecosystem development, and platform technologies. Mr. Noor will also serve as the Chief of Staff to the CEO.
Before joining Zimmer Biomet, Mr. Noor was President and Managing Director for Europe, Africa, and Asia at Trivium, where he led a successful transformation strategy to drive operational excellence, margin improvement, and cash expansion. Prior to his tenure at Trivium, he served as CEO of Smiths Medical for three years. Mr. Noor also held leadership positions at Amcor, McKinsey, Ford Motor Company, and Constellation Energy Commodities Group.
Mr. Noor earned a Master of Science in Product Development, a Bachelor of Science in Finance, and a Bachelor of Science in Mechanical Engineering, all from the Massachusetts Institute of Technology (MIT).